THEODORE SHIVELY: Open Payments
NPI 1780666461 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,183 in 57 payments from 17 companies in 2025. Trend: 2023 $1,135 · 2024 $1,255 · 2025 $1,183
Food & beverage: $1,183
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $418 |
| Lilly USA, LLC | 12 | $189 |
| ABBVIE INC. | 5 | $125 |
| Exact Sciences Corporation | 4 | $66 |
| PFIZER INC. | 3 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $27 |
| Eisai Inc. | 1 | $24 |
Products named: Wegovy, Rybelsus, MOUNJARO, The Cologuard Plus Collection Kit, PREVNAR 20, KISUNLA, VRAYLAR, REXULTI.
Industry payments across MI — which companies pay providers there.
